According to the latest report, at the Huawei Sports Health Innovation Technology Communication Conference, Zhang Wei, CEO of Huawei Sports Health Corps and President of Huawei’s Terminal Business Smart Wear and Sports Health Product Line, said that by the end of 2021, Huawei cumulative global shipment of wear exceeds 100 million, the global cumulative user volume exceeds 350 million, and it cooperates with more than 80 global research institutions.
Moreover, according to the canalys data, global shipments of wearable wristband devices will reach 193 million units in 2021, a year-on-year increase of 4.3%. Among them, due to the influence of overseas policies and the separation of Honor, Huawei’s market share fell by nearly 7%, and its shipments fell by 40% year-on-year, but it still ranked third with 19 million units shipped. In the mainland Chinese market, Huawei ranks first with a market share of 30%.
In addition, Zhang Wei also announced the three major health research projects that Huawei is promoting, including innovative blood sugar, lung function health, and high altitude health research.
In April this year, Huawei released the WATCH GT 3 Pro series of smartwatches. In terms of health functions, it is fully equipped with ECG acquisition function, Huawei ECG analysis prompt software, and also supports all-weather heart rate monitoring, continuous blood Oxygen monitoring, altitude blood oxygen monitoring, body temperature monitoring, and scientific sleep monitoring, pressure monitoring, etc.